News

Carilion Clinic promotes COO Arner to president

Nancy Agee remains CEO of Roanoke health care system

Roanoke, VA /Virginia Business/ Carilion Clinic has promoted its executive vice president and chief operating officer, Steve Arner, to president of the Roanoke-based nonprofit health system. He will remain COO while taking on new duties as president, Carilion said in its announcement Tuesday.

Nancy Howell Agee, who has served as CEO and president since 2011, will also continue as CEO.

In addition to serving as Carilion Clinic’s COO and executive vice president for the health care organization’s Roanoke operations since 2012, Arner has been president and CEO of the 703-bed Level 1 trauma center Carilion Medical Center since 2014. As president, Arner will oversee day-to-day management of the $2.4 billion health system’s seven hospitals and more than 240 medical offices.

He also played a significant role in the state’s COVID-19 response as chair of the Virginia Hospital and Healthcare Association from October 2020 through April 2022.

After joining Carilion in 2005, Arner held leadership roles in hospital administration, cardiac and vascular services, surgical services and facility management, and he also was president and CEO of Carilion Rockbridge Community Hospital. In 2003, Arner earned an MBA from Brigham Young University.

During his time with Carilion, Arner helped spearhead capital improvements, including the Crystal Spring Tower addition to Carilion Roanoke Memorial Hospital, which will be completed in 2025.

“Steve is an outstanding leader, and we are delighted to promote him,” Agee said in a statement. “He has a strong work ethic and cares deeply about our patients, our teams and our work together caring for the communities we serve.”

As VHHA chair, Arner coordinated the collective response of Virginia’s health care provider organizations to the pandemic, and he has served on the VHHA board since 2014 and its executive committee since 2015. Arner was also state delegate to the American Hospital Association Regional Policy Board from 2016 to 2021 and serves on the strategic planning committee for America’s Essential Hospitals.

“Carilion today is a nationally ranked academic health system that provides an extraordinary range of services, from primary care to the most advanced, complex care,” Arner said in a statement. “I look forward to continuing on a pathway of growth and collaboration.”

Read more here.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia.

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and